Celebrating a curious mind: Steven Keating 1988-2019
Steven Keating SM'12, PhD '16 inspired millions with his research-driven approach to battling cancer and his advocacy for open patient health data.
Unmasking mutant cancer cells
A new dosing regimen for an old cancer drug shows new promise as an immunotherapy.
New vaccine strategy boosts T-cell therapy
Super-charging a treatment for leukemia also makes it effective on solid tumors.
World-class diagnostics for low-income communities in sub-Saharan Africa
MDaaS Global works to transform health care in Africa by bringing high-end medical diagnostics to low-income communities.
Cancer biologists identify new drug combo
Two drugs that block cell division synergize to kill tumor cells.
Ankita Reddy ’19 blends anthropology and biology to improve public health
Recent graduate says culturally-aware approaches lead to more-effective medical interventions.
Drag-and-drop data analytics
System lets nonspecialists use machine-learning models to make predictions for medical research, sales, and more.
Confining cell-killing treatments to tumors
Attaching a Velcro-like molecule may prevent immune proteins called cytokines from leaking out of cancerous tissue after injection.
Study: Social robots can benefit hospitalized children
Interacting with a robotic teddy bear invented at MIT boosted young patients’ positive emotions, engagement, and activity level.
Chemists discover structure of glucagon fibrils
Study may be a step toward shelf-stable versions of the hormone, which is used to control diabetes.
A better way to encapsulate islet cells for diabetes treatment
Crystallized drug prevents immune system rejection of transplanted pancreatic islet cells.
“Nanoemulsion” gels offer new way to deliver drugs through the skin
Novel materials made with FDA-approved components could deliver large payloads of active ingredients.
From one brain scan, more information for medical artificial intelligence
System helps machine-learning models glean training information for diagnosing and treating brain conditions.
Drug makes tumors more susceptible to chemo
Compound that knocks out a DNA repair pathway enhances cisplatin treatment and helps prevent drug-resistance.
Biotech startup uses nanoparticles to induce immune tolerance
Selecta Bioscience’s ImmTOR platform could improve gene therapies and prevent some drug side effects.